1. (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)-
2. (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)-, Monohydrochloride
3. 4''-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)-2-biphenylcarboxanilide
4. Ci-1025
5. Conivaptan
6. Conivaptan Hcl
7. Vaprisol
8. Ym 087
9. Ym-087
10. Ym087
1. 168626-94-6
2. Conivaptan Hcl
3. Vaprisol
4. Ym 087
5. Conivaptan (hydrochloride)
6. Ci-1025
7. Conivaptan Hydrochloride [usan]
8. Ym-087
9. N-[4-(2-methyl-4,5-dihydro-3h-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide Hydrochloride
10. Ym087
11. Conivaptan Hcl (vaprisol)
12. 8626-94-6
13. Chebi:31430
14. 75l57r6x36
15. (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)-, Monohydrochloride
16. [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl]-, Hydrochloride (1:1)
17. 4'-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)-2-biphenylcarboxanilide Monohydrochloride
18. N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide Hydrochloride
19. 4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide Monohydrochloride
20. N-[4-({4-methyl-3,5,9-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),2(6),4,10,12-pentaen-9-yl}carbonyl)phenyl]-2-phenylbenzamide Hydrochloride
21. Smr004701209
22. Unii-75l57r6x36
23. Vaprisol (tn)
24. Mls006010030
25. Mls006010233
26. Schembl387232
27. Conivaptan Hcl [vandf]
28. Chembl1201108
29. Dtxsid70168585
30. Vaprisol, Conivaptan Hydrochloride
31. Bcp28426
32. Ex-a1128
33. Conivaptan Hydrochloride (jan/usan)
34. Conivaptan Hydrochloride [mi]
35. Hy-18347a
36. Mfcd00945712
37. Conivaptan Hydrochloride [jan]
38. Akos015994583
39. Akos025401635
40. Ccg-269940
41. Cs-2015
42. Fe-0225
43. Conivaptan Hydrochloride [mart.]
44. Conivaptan Hydrochloride [who-dd]
45. Ac-23918
46. N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide Hydrochloride
47. Db-064699
48. Am20090724
49. Ft-0657174
50. Sw219215-1
51. Conivaptan Hydrochloride [orange Book]
52. D01236
53. 626c946
54. A810997
55. J-010472
56. Q27114306
57. 4''-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)-2-biphenylcarboxanilide Monohydrochloride
58. 4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide Hydrochloride
59. N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamidehydrochloride
60. N-[4-(2-methyl-4,5-dihydro-1h-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride
61. N-[4-(2-methyl-4,5-dihydro-3h-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride
62. N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl]-[1,1?-biphenyl]-2-carboxamide Hydrochloride
63. N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl}biphenyl-2-carboxamide Hydrochloride
Molecular Weight | 535.0 g/mol |
---|---|
Molecular Formula | C32H27ClN4O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 534.1822538 g/mol |
Monoisotopic Mass | 534.1822538 g/mol |
Topological Polar Surface Area | 78.1 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 820 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Vaprisol |
PubMed Health | Conivaptan (Injection) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride, having a molecular weight of 535.04 and molecular formula C32H26N4O2HCl. Th... |
Active Ingredient | Conivaptan hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 20mg |
Market Status | Prescription |
Company | Astellas |
2 of 2 | |
---|---|
Drug Name | Vaprisol |
PubMed Health | Conivaptan (Injection) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride, having a molecular weight of 535.04 and molecular formula C32H26N4O2HCl. Th... |
Active Ingredient | Conivaptan hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 20mg |
Market Status | Prescription |
Company | Astellas |
Antidiuretic Hormone Receptor Antagonists
Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)
LOOKING FOR A SUPPLIER?